Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 (ST8SIA4) is an enzyme that catalyzes the transfer of sialic acid residues to alpha-2,8-linked positions on glycoproteins, primarily generating polysialic acid—a crucial modulator of neural cell adhesion molecule (NCAM1) function. It is a member of the glycosyltransferase family 29 and is primarily located in the Golgi apparatus as a type II membrane protein[1][2][6]. ST8SIA4 has an essential role in regulating cell-cell adhesion in neural tissues and is implicated in various developmental and disease processes, including tumor progression, metastasis, and chemoresistance in certain cancers[5].
Inhibition of ST8SIA4 would reduce polysialic acid synthesis, altering neural cell adhesion and potentially affecting tumor cell migration and invasion. Modulation of its activity impacts the PI3K/Akt signaling pathway in some cancer types (such as in chronic myeloid leukemia)[5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 (ST8SIA4).